Home

About

Advanced Search

Browse by Discipline

Scientific Societies

E-print Alerts

Add E-prints

E-print Network
FAQHELPSITE MAPCONTACT US


  Advanced Search  

 
CANCER BIOTHERAPY & RADIOPHARMACEUTICALS Volume 16, Number 6, 2001
 

Summary: CANCER BIOTHERAPY & RADIOPHARMACEUTICALS
Volume 16, Number 6, 2001
Mary Ann Liebert, Inc.
Editorial
Metabolism of Radiometal-Labeled Proteins and
Peptides: What are the Real Radiopharmaceuticals
in vivo?
Carolyn J. Anderson
Mallinckrodt Institute of Radiology, Department of Molecular Biology and Pharmacology, Washington
University School of Medicine, St. Louis, MO
451
RADIOMETAL-LABELED
MONOCLONAL ANTIBODIES
AND PEPTIDES
The radiolabeling of monoclonal antibodies
(mAbs) for the detection of cancer in the 1970's13
marked the beginning of the use of radiolabeled bi-
ological molecules for targeting antigens and re-
ceptors that are upregulated in tumors. Initially, ra-
diolabeled antibodies were labeled with iodine

  

Source: Anderson, Carolyn J. - Department of Molecular Biology and Pharmacology, Washington University in St. Louis

 

Collections: Biology and Medicine